B D Fear|A Cutler|S Butterfield - JoVE Visualize

Showing results (221-230 of 312) with videos related to

Pageof 32

Sort By:

JAMA|August 11, 1993

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research GroupJ D Neaton, R H Grimm, R J Prineas, et al.

JAMA|October 17, 2002

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education ProgramPaul K Whelton, Jiang He, Lawrence J Appel, et al.

JAMA|December 25, 1987

Change in physician perspective on cholesterol and heart disease. Results from two national surveysB Schucker, J T Wittes, J A Cutler, et al.

Human Molecular Genetics|January 13, 2006

Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regenerationGisela Melcon, Serguei Kozlov, Dedra A Cutler, et al.

Archives of Internal Medicine|November 15, 2006

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Joshua I Barzilay, Barry R Davis, Jeffrey A Cutler, et al.

Journal of Clinical Hypertension (Greenwich, Conn.)|January 9, 2009

Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by cliniciansChuke E Nwachuku, Arnaud Bastien, Jeffrey A Cutler, et al.

JAMA|December 25, 1987

Change in public perspective on cholesterol and heart disease. Results from two national surveysB Schucker, K Bailey, J T Heimbach, et al.

Molecular Therapy. Methods & Clinical Development|November 4, 2020

Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.

Hypertension (Dallas, Tex. : 1979)|October 1, 1993

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research GroupS K Kumanyika, P R Hebert, J A Cutler, et al.

Journal of Hypertension|February 1, 1994

Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension PreventionF M Sacks, P Hebert, L J Appel, et al.

Pageof 32

Showing results (221-230 of 312) with videos related to

Sort By:

Pageof 32

JAMA|August 11, 1993

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research GroupJ D Neaton, R H Grimm, R J Prineas, et al.

JAMA|October 17, 2002

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education ProgramPaul K Whelton, Jiang He, Lawrence J Appel, et al.

JAMA|December 25, 1987

Change in physician perspective on cholesterol and heart disease. Results from two national surveysB Schucker, J T Wittes, J A Cutler, et al.

Human Molecular Genetics|January 13, 2006

Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regenerationGisela Melcon, Serguei Kozlov, Dedra A Cutler, et al.

Archives of Internal Medicine|November 15, 2006

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Joshua I Barzilay, Barry R Davis, Jeffrey A Cutler, et al.

Journal of Clinical Hypertension (Greenwich, Conn.)|January 9, 2009

Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by cliniciansChuke E Nwachuku, Arnaud Bastien, Jeffrey A Cutler, et al.

JAMA|December 25, 1987

Change in public perspective on cholesterol and heart disease. Results from two national surveysB Schucker, K Bailey, J T Heimbach, et al.

Molecular Therapy. Methods & Clinical Development|November 4, 2020

Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.

Hypertension (Dallas, Tex. : 1979)|October 1, 1993

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research GroupS K Kumanyika, P R Hebert, J A Cutler, et al.

Journal of Hypertension|February 1, 1994

Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension PreventionF M Sacks, P Hebert, L J Appel, et al.

Pageof 32